array(40) {
  [0]=>
  string(4) "1812"
  ["article_id"]=>
  string(4) "1812"
  [1]=>
  string(50) "EU approves new dosing schedule for MSD's Keytruda"
  ["article_title"]=>
  string(50) "EU approves new dosing schedule for MSD's Keytruda"
  [2]=>
  string(108) "The less frequent dosing gives both patients and oncologists more flexibility, helping to free up hospitals."
  ["short_description"]=>
  string(108) "The less frequent dosing gives both patients and oncologists more flexibility, helping to free up hospitals."
  [3]=>
  string(108) "The less frequent dosing gives both patients and oncologists more flexibility, helping to free up hospitals."
  ["description"]=>
  string(108) "The less frequent dosing gives both patients and oncologists more flexibility, helping to free up hospitals."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(89) "http://www.pharmatimes.com/news/eu_approves_new_dosing_schedule_for_msds_keytruda_1283608"
  ["blog_url"]=>
  string(89) "http://www.pharmatimes.com/news/eu_approves_new_dosing_schedule_for_msds_keytruda_1283608"
  [15]=>
  string(19) "2019-04-05 16:46:05"
  ["add_date"]=>
  string(19) "2019-04-05 16:46:05"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-08 15:10:57"
  ["create_at"]=>
  string(19) "2019-04-08 15:10:57"
  [19]=>
  string(50) "EU_approves_new_dosing_schedule_for_MSD_s_Keytruda"
  ["slug"]=>
  string(50) "EU_approves_new_dosing_schedule_for_MSD_s_Keytruda"
}
                    

array(40) {
  [0]=>
  string(4) "1938"
  ["article_id"]=>
  string(4) "1938"
  [1]=>
  string(118) "Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Biologics License Application to U.S. FDA"
  ["article_title"]=>
  string(118) "Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Biologics License Application to U.S. FDA"
  [2]=>
  string(150) "SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE) April 05, 2019 -- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) tod"
  ["short_description"]=>
  string(150) "SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE) April 05, 2019 -- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) tod"
  [3]=>
  string(251) "SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE) April 05, 2019 -- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that Celgene has submitted a Biologics License Application (BLA) for luspatercept, an..."
  ["description"]=>
  string(251) "SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE) April 05, 2019 -- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that Celgene has submitted a Biologics License Application (BLA) for luspatercept, an..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(212) "https://www.drugs.com/nda/luspatercept_190405.html?utm_source=ddc&utm_medium=rss&utm_campaign=Celgene+Corporation+and+Acceleron+Pharma+Announce+Submission+of+Luspatercept+Biologics+License+Application+to+U.S.+FDA"
  ["blog_url"]=>
  string(212) "https://www.drugs.com/nda/luspatercept_190405.html?utm_source=ddc&utm_medium=rss&utm_campaign=Celgene+Corporation+and+Acceleron+Pharma+Announce+Submission+of+Luspatercept+Biologics+License+Application+to+U.S.+FDA"
  [15]=>
  string(19) "2019-04-05 11:04:38"
  ["add_date"]=>
  string(19) "2019-04-05 11:04:38"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:51"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5913"
  ["article_id"]=>
  string(4) "5913"
  [1]=>
  string(38) "Borderlines between Medicines and Food"
  ["article_title"]=>
  string(38) "Borderlines between Medicines and Food"
  [2]=>
  string(150) "This seminar aims to assist delegates to an understanding of how the borderline between medicines and foods may be defined and how best to tailor the "
  ["short_description"]=>
  string(150) "This seminar aims to assist delegates to an understanding of how the borderline between medicines and foods may be defined and how best to tailor the "
  [3]=>
  string(519) "This seminar aims to assist delegates to an understanding of how the borderline between medicines and foods may be defined and how best to tailor the presentation of their products to the regulatory structure appropriate to them.&#nlCourse Overview&#nl&#nlMedicines treat, cure or prevent illness. Foods provide nutrition. But are the distinctions so clear?&#nlFoods also have a physiological effect and a role in disease risk reduction – and substances whose purpose is nutritional may be presented as medici..."
  ["description"]=>
  string(519) "This seminar aims to assist delegates to an understanding of how the borderline between medicines and foods may be defined and how best to tailor the presentation of their products to the regulatory structure appropriate to them.&#nlCourse Overview&#nl&#nlMedicines treat, cure or prevent illness. Foods provide nutrition. But are the distinctions so clear?&#nlFoods also have a physiological effect and a role in disease risk reduction – and substances whose purpose is nutritional may be presented as medici..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(70) "https://www.pharmiweb.com/event/borderlines-between-medicines-and-food"
  ["blog_url"]=>
  string(70) "https://www.pharmiweb.com/event/borderlines-between-medicines-and-food"
  [15]=>
  string(19) "2019-04-05 09:42:12"
  ["add_date"]=>
  string(19) "2019-04-05 09:42:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-11-11 12:49:42"
  ["create_at"]=>
  string(19) "2019-11-11 12:49:42"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2128"
  ["article_id"]=>
  string(4) "2128"
  [1]=>
  string(68) "Skills, Pills, & Hospital Bills: Amazon Debuts Alexa Health Features"
  ["article_title"]=>
  string(68) "Skills, Pills, & Hospital Bills: Amazon Debuts Alexa Health Features"
  [2]=>
  string(155) "Owners of Amazon’s voice-controlled, Internet-connected speakers can now use the gadgets to manage more aspects of their healthcare, following the c"
  ["short_description"]=>
  string(155) "Owners of Amazon’s voice-controlled, Internet-connected speakers can now use the gadgets to manage more aspects of their healthcare, following the c"
  [3]=>
  string(441) "Owners of Amazon’s voice-controlled, Internet-connected speakers can now use the gadgets to manage more aspects of their healthcare, following the company’s announcement Thursday that its Alexa devices can interface with software applications that process protected health information. As part of the announcement, Amazon (NASDAQ: AMZN) unveiled six “Alexa healthcare skills,” which allow patients to book […]"
  ["description"]=>
  string(441) "Owners of Amazon’s voice-controlled, Internet-connected speakers can now use the gadgets to manage more aspects of their healthcare, following the company’s announcement Thursday that its Alexa devices can interface with software applications that process protected health information. As part of the announcement, Amazon (NASDAQ: AMZN) unveiled six “Alexa healthcare skills,” which allow patients to book […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "37"
  ["rss_id"]=>
  string(2) "37"
  [14]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/2KT6T59ZYaY/"
  ["blog_url"]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/2KT6T59ZYaY/"
  [15]=>
  string(19) "2019-04-05 06:44:41"
  ["add_date"]=>
  string(19) "2019-04-05 06:44:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1813"
  ["article_id"]=>
  string(4) "1813"
  [1]=>
  string(59) "Brexit will have "minimal" effect on R&D in UK, says expert"
  ["article_title"]=>
  string(59) "Brexit will have "minimal" effect on R&D in UK, says expert"
  [2]=>
  string(158) "The NIHR's Dr Jonathan Sheffield gave a positive outlook on UK R&D post-Brexit at the 'Brexit: What's Next for Pharma?’ PING conference."
  ["short_description"]=>
  string(158) "The NIHR's Dr Jonathan Sheffield gave a positive outlook on UK R&D post-Brexit at the 'Brexit: What's Next for Pharma?’ PING conference."
  [3]=>
  string(158) "The NIHR's Dr Jonathan Sheffield gave a positive outlook on UK R&D post-Brexit at the 'Brexit: What's Next for Pharma?’ PING conference."
  ["description"]=>
  string(158) "The NIHR's Dr Jonathan Sheffield gave a positive outlook on UK R&D post-Brexit at the 'Brexit: What's Next for Pharma?’ PING conference."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(101) "http://www.pharmatimes.com/news/brexit_will_have_minimal_effect_on_r_and_d_in_uk,_says_expert_1283463"
  ["blog_url"]=>
  string(101) "http://www.pharmatimes.com/news/brexit_will_have_minimal_effect_on_r_and_d_in_uk,_says_expert_1283463"
  [15]=>
  string(19) "2019-04-04 19:49:09"
  ["add_date"]=>
  string(19) "2019-04-04 19:49:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-08 15:10:57"
  ["create_at"]=>
  string(19) "2019-04-08 15:10:57"
  [19]=>
  string(59) "Brexit_will_have__minimal__effect_on_R_D_in_UK__says_expert"
  ["slug"]=>
  string(59) "Brexit_will_have__minimal__effect_on_R_D_in_UK__says_expert"
}
                    

array(40) {
  [0]=>
  string(4) "1814"
  ["article_id"]=>
  string(4) "1814"
  [1]=>
  string(62) "Big Pharma come together for better drug side effect detection"
  ["article_title"]=>
  string(62) "Big Pharma come together for better drug side effect detection"
  [2]=>
  string(89) "The group will consist of pharma giants like Pfizer, Celgene, Roche and BMS among others."
  ["short_description"]=>
  string(89) "The group will consist of pharma giants like Pfizer, Celgene, Roche and BMS among others."
  [3]=>
  string(89) "The group will consist of pharma giants like Pfizer, Celgene, Roche and BMS among others."
  ["description"]=>
  string(89) "The group will consist of pharma giants like Pfizer, Celgene, Roche and BMS among others."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(102) "http://www.pharmatimes.com/news/big_pharma_come_together_for_better_drug_side_effect_detection_1283418"
  ["blog_url"]=>
  string(102) "http://www.pharmatimes.com/news/big_pharma_come_together_for_better_drug_side_effect_detection_1283418"
  [15]=>
  string(19) "2019-04-04 19:40:43"
  ["add_date"]=>
  string(19) "2019-04-04 19:40:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-08 15:10:57"
  ["create_at"]=>
  string(19) "2019-04-08 15:10:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4861"
  ["article_id"]=>
  string(4) "4861"
  [1]=>
  string(76) "16th International Conference on Pharmaceutical Formulations & Drug Delivery"
  ["article_title"]=>
  string(76) "16th International Conference on Pharmaceutical Formulations & Drug Delivery"
  [2]=>
  string(150) "After the successful completion of the 15th International Conference on Pharmaceutical Formulations & Drug Delivery, Conference Series LLC Ltd"
  ["short_description"]=>
  string(150) "After the successful completion of the 15th International Conference on Pharmaceutical Formulations & Drug Delivery, Conference Series LLC Ltd"
  [3]=>
  string(508) "After the successful completion of the 15th International Conference on Pharmaceutical Formulations & Drug Delivery, Conference Series LLC Ltd with great pride and honour announcing its 16th International Conference on Pharmaceutical Formulations & Drug Delivery which is going to held in Amsterdam, Netherlands during October 23-24, 2019. This Pharma Formulations 2019 includes a wide range of Keynote presentations, plenary talks, Symposia, Workshops, Exhibitions, Poster presentations a..."
  ["description"]=>
  string(508) "After the successful completion of the 15th International Conference on Pharmaceutical Formulations & Drug Delivery, Conference Series LLC Ltd with great pride and honour announcing its 16th International Conference on Pharmaceutical Formulations & Drug Delivery which is going to held in Amsterdam, Netherlands during October 23-24, 2019. This Pharma Formulations 2019 includes a wide range of Keynote presentations, plenary talks, Symposia, Workshops, Exhibitions, Poster presentations a..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(106) "https://www.pharmiweb.com/event/16th-international-conference-on-pharmaceutical-formulations-drug-delivery"
  ["blog_url"]=>
  string(106) "https://www.pharmiweb.com/event/16th-international-conference-on-pharmaceutical-formulations-drug-delivery"
  [15]=>
  string(19) "2019-04-04 19:40:22"
  ["add_date"]=>
  string(19) "2019-04-04 19:40:22"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-27 14:12:08"
  ["create_at"]=>
  string(19) "2019-09-27 14:12:08"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1815"
  ["article_id"]=>
  string(4) "1815"
  [1]=>
  string(42) "Boots introduces new at-home health checks"
  ["article_title"]=>
  string(42) "Boots introduces new at-home health checks"
  [2]=>
  string(85) "The tests include vitamin D, cholesterol, diabetes, and iron deficiency among others."
  ["short_description"]=>
  string(85) "The tests include vitamin D, cholesterol, diabetes, and iron deficiency among others."
  [3]=>
  string(85) "The tests include vitamin D, cholesterol, diabetes, and iron deficiency among others."
  ["description"]=>
  string(85) "The tests include vitamin D, cholesterol, diabetes, and iron deficiency among others."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(82) "http://www.pharmatimes.com/news/boots_introduces_new_at-home_health_checks_1283410"
  ["blog_url"]=>
  string(82) "http://www.pharmatimes.com/news/boots_introduces_new_at-home_health_checks_1283410"
  [15]=>
  string(19) "2019-04-04 19:35:38"
  ["add_date"]=>
  string(19) "2019-04-04 19:35:38"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-08 15:10:57"
  ["create_at"]=>
  string(19) "2019-04-08 15:10:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1821"
  ["article_id"]=>
  string(4) "1821"
  [1]=>
  string(79) "Speaker Spotlight: MedSec’s Stephanie Domas on State of Cybersecurity"
  ["article_title"]=>
  string(79) "Speaker Spotlight: MedSec’s Stephanie Domas on State of Cybersecurity"
  [2]=>
  string(163) "Domas to share her insights at the MedTech Intelligence Cybersecurity conference in June 4–5 in Boston.&#nlThe post Speaker Spotlight: MedSec’s Steph"
  ["short_description"]=>
  string(163) "Domas to share her insights at the MedTech Intelligence Cybersecurity conference in June 4–5 in Boston.&#nlThe post Speaker Spotlight: MedSec’s Steph"
  [3]=>
  string(506) "
Domas to share her insights at the MedTech Intelligence Cybersecurity conference in June 4–5 in Boston.
&#nl
The post Speaker Spotlight: MedSec’s Stephanie Domas on State of Cybersecurity appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(506) "
Domas to share her insights at the MedTech Intelligence Cybersecurity conference in June 4–5 in Boston.
&#nl
The post Speaker Spotlight: MedSec’s Stephanie Domas on State of Cybersecurity appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(117) "https://www.medtechintelligence.com/news_article/speaker-spotlight-medsecs-stephanie-domas-on-state-of-cybersecurity/"
  ["blog_url"]=>
  string(117) "https://www.medtechintelligence.com/news_article/speaker-spotlight-medsecs-stephanie-domas-on-state-of-cybersecurity/"
  [15]=>
  string(19) "2019-04-04 19:00:15"
  ["add_date"]=>
  string(19) "2019-04-04 19:00:15"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-15 14:56:01"
  ["create_at"]=>
  string(19) "2019-04-15 14:56:01"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5294"
  ["article_id"]=>
  string(4) "5294"
  [1]=>
  string(65) "Clinical Discussions in Anesthesiology and Perioperative Medicine"
  ["article_title"]=>
  string(65) "Clinical Discussions in Anesthesiology and Perioperative Medicine"
  [2]=>
  string(150) "This Conference is designed for discussion, fact-finding, problem solving of physicians and nurses, anesthesia assistants and hospital administration "
  ["short_description"]=>
  string(150) "This Conference is designed for discussion, fact-finding, problem solving of physicians and nurses, anesthesia assistants and hospital administration "
  [3]=>
  string(503) "This Conference is designed for discussion, fact-finding, problem solving of physicians and nurses, anesthesia assistants and hospital administration personnel, while we meet and exchange views, in an open debate, and give publicity to some new areas in anesthesia, critical care, pain therapy, surgery, medicine, cardiology, and quality and safety.&#nlThis Conference will excel in innovation in conference topics, topics facing the future of anesthesia. Topics of high-end technology and novel meth..."
  ["description"]=>
  string(503) "This Conference is designed for discussion, fact-finding, problem solving of physicians and nurses, anesthesia assistants and hospital administration personnel, while we meet and exchange views, in an open debate, and give publicity to some new areas in anesthesia, critical care, pain therapy, surgery, medicine, cardiology, and quality and safety.&#nlThis Conference will excel in innovation in conference topics, topics facing the future of anesthesia. Topics of high-end technology and novel meth..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(97) "https://www.pharmiweb.com/event/clinical-discussions-in-anesthesiology-and-perioperative-medicine"
  ["blog_url"]=>
  string(97) "https://www.pharmiweb.com/event/clinical-discussions-in-anesthesiology-and-perioperative-medicine"
  [15]=>
  string(19) "2019-04-04 18:25:25"
  ["add_date"]=>
  string(19) "2019-04-04 18:25:25"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1816"
  ["article_id"]=>
  string(4) "1816"
  [1]=>
  string(103) "Finalists announced for the 2019 PharmaTimes Clinical Researcher of the Year- The Americas competition!"
  ["article_title"]=>
  string(103) "Finalists announced for the 2019 PharmaTimes Clinical Researcher of the Year- The Americas competition!"
  [2]=>
  string(150) "The judging panels have analysed all of the entries for this year’s competition and have decided on the individuals and teams who will be progre"
  ["short_description"]=>
  string(150) "The judging panels have analysed all of the entries for this year’s competition and have decided on the individuals and teams who will be progre"
  [3]=>
  string(186) "The judging panels have analysed all of the entries for this year’s competition and have decided on the individuals and teams who will be progressing to our live finals day in May."
  ["description"]=>
  string(186) "The judging panels have analysed all of the entries for this year’s competition and have decided on the individuals and teams who will be progressing to our live finals day in May."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(142) "http://www.pharmatimes.com/news/finalists_announced_for_the_2019_pharmatimes_clinical_researcher_of_the_year_the_americas_competition!_1283366"
  ["blog_url"]=>
  string(142) "http://www.pharmatimes.com/news/finalists_announced_for_the_2019_pharmatimes_clinical_researcher_of_the_year_the_americas_competition!_1283366"
  [15]=>
  string(19) "2019-04-04 18:15:53"
  ["add_date"]=>
  string(19) "2019-04-04 18:15:53"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-08 15:10:57"
  ["create_at"]=>
  string(19) "2019-04-08 15:10:57"
  [19]=>
  string(103) "Finalists_announced_for_the_2019_PharmaTimes_Clinical_Researcher_of_the_Year-_The_Americas_competition_"
  ["slug"]=>
  string(103) "Finalists_announced_for_the_2019_PharmaTimes_Clinical_Researcher_of_the_Year-_The_Americas_competition_"
}
                    

array(40) {
  [0]=>
  string(4) "1999"
  ["article_id"]=>
  string(4) "1999"
  [1]=>
  string(101) "Immunocore’s Lead Asset Tebentafusp Gains Fast Track Designation for Metastatic Uveal Melanoma"
  ["article_title"]=>
  string(101) "Immunocore’s Lead Asset Tebentafusp Gains Fast Track Designation for Metastatic Uveal Melanoma"
  [2]=>
  string(150) "OXFORD, England & CONSHOHOCKEN, Pa.--April 03, 2019 --Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces t"
  ["short_description"]=>
  string(150) "OXFORD, England & CONSHOHOCKEN, Pa.--April 03, 2019 --Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces t"
  [3]=>
  string(243) "OXFORD, England & CONSHOHOCKEN, Pa.--April 03, 2019 --Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its..."
  ["description"]=>
  string(243) "OXFORD, England & CONSHOHOCKEN, Pa.--April 03, 2019 --Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(285) "https://www.drugs.com/clinical_trials/immunocore-s-lead-asset-tebentafusp-gains-fast-track-designation-metastatic-uveal-melanoma-18109.html?utm_source=ddc&utm_medium=rss&utm_campaign=Immunocore%E2%80%99s+Lead+Asset+Tebentafusp+Gains+Fast+Track+Designation+for+Metastatic+Uveal+Melanoma"
  ["blog_url"]=>
  string(285) "https://www.drugs.com/clinical_trials/immunocore-s-lead-asset-tebentafusp-gains-fast-track-designation-metastatic-uveal-melanoma-18109.html?utm_source=ddc&utm_medium=rss&utm_campaign=Immunocore%E2%80%99s+Lead+Asset+Tebentafusp+Gains+Fast+Track+Designation+for+Metastatic+Uveal+Melanoma"
  [15]=>
  string(19) "2019-04-04 13:04:06"
  ["add_date"]=>
  string(19) "2019-04-04 13:04:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}